Competitor Analysis: Enzyme Replacement Therapies

Publisher: La Merie Publishing
Pages: 74
Format: PDF
Product Line:
Competitor Analysis
Product Code: LMCA0032
Release Date: January of 2013

300.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Enzyme Replacement & Enhancement Therapies (ERT)


Product description

The Competitive Intelligence Report Enzyme Replacement & Enhancement   Therapies (ERT) as of January 2013 provides a competitor analysis in   the development pipeline of novel enzyme replacement therapies and of   enzyme enhancement therapies to treat human genetic diseases/lysosomal   storage diseases and exocrine pancreatic insufficiency due to cystic   fibrosis, pancreatitis and other causes.


Purchase of the downloadable pdf report includes a 6-month online   access to the data of the report and any updates since the publication   date. Credentials to access the database will be sent by e-mail and   allow online work with the project data to print or export an individual   report.


The report includes a compilation of current active projects in   research and development of novel enzyme replacement & enhancement   therapy products and an overview of approved products. In addition, the   report lists company-specific product portfolios and R&D pipelines   of enzyme replacement and enhancement therapies. Competitor projects are   listed in a tabular format providing Information on:

  • Drug Codes,
  • Target / Mechanism of Action, 
  • Class of Compound, 
  • Company, 
  • Product Category, 
  • Indication, 
  • R&D Stage and 
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise   information about the pipeline of R&D projects for targets,   diseases, technologies and companies at low prices. The information is   provided in a tabular format and fully referenced.

Enzyme Replacement & Enhancement Therapies (ERT)

Table of Contents

  • Gaucher Disease
  • Fabry Disease
  • Pompé Disease
  • Hunter Disease (MPS II)
  • Niemann Pick Diseases
  • Mucopolysaccharidosis I (MPS I)
  • San Filippo Syndrome (MPS IIIA)
  • Morquio Syndrome (MPS IVA)
  • Mucopolysaccharidosis VI (MPS VI)
  • Tay-Sachs Disease
  • Chronic Deficiency of Adenosine Deaminase
  • Phenylketonuria / Hyperphenylalaninemia
  • Other Enzyme Replacement Therapies
  • Exocrine Pancreatic Insufficiency: Porcine-Derived ERT
  • Exocrine Pancreatic Insufficiency: Recombinant ERT
  • Others



The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up